Disc Medicine (IRON) Operating Leases (2021 - 2026)
Disc Medicine's (IRON) quarterly Operating Leases came in at $1.3 million in Q1 2026, down 21.85% year-on-year from $1.6 million in Q1 2025, and up 1.92% on a QoQ basis from $1.3 million in Q4 2025.
Disc Medicine (IRON) Operating Leases (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Operating Leases data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Operating Leases fell 21.85% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 21.85% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 19.06% from the prior year.
- Operating Leases for Q1 2026 stood at $1.3 million, up from $1.3 million in the prior quarter.
- Over the last five years, Operating Leases for IRON reached as high as $1.8 million in Q2 2023 and fell as low as $945000.0 in Q1 2023.
- Historically, Operating Leases has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
- Across the five-year window, Operating Leases tumbled 39.16% in 2024 and jumped 44.06% in 2025, its largest moves.
- Year by year, Operating Leases stood at $1.0 million in 2022, then surged by 39.82% to $1.4 million in 2023, then climbed by 7.8% to $1.5 million in 2024, then decreased by 19.06% to $1.3 million in 2025, then climbed by 1.92% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 945,000.00 |
| Dec 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.33 Mn |